Angela Burnett, NP
Family · Jacksonville, FLNPI 1427334820
Payments from drug & device makers
Across 131 payments — averaging $53.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$5K
- Inari Medical, Inc.$377
- Actelion Pharmaceuticals US, Inc.$344
- AstraZeneca$208
- GSK$169
- Boehringer Ingelheim$135
- plus $876 from 16 others
What the payments were for
- Travel & lodging$2,34333%
- Food & beverage$4,63366%
- Education$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 72 | $4,923 |
| Inari Medical, Inc. | 3 | $377 |
| Actelion Pharmaceuticals US, Inc. | 3 | $344 |
| AstraZeneca | 6 | $208 |
| GSK | 10 | $169 |
| Boehringer Ingelheim | 7 | $135 |
| Medtronic | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 3 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Inogen, Inc. | 3 | $81 |
| Grifols USA, LLC | 3 | $64 |
| Merck | 2 | $56 |
| Mallinckrodt Hospital Products Inc. | 2 | $54 |
| Harmony Biosciences LLC | 1 | $53 |
| Viatris Specialty LLC | 3 | $49 |
| Pulmonx Corporation | 1 | $36 |
| Ambu Inc. | 1 | $34 |
| Sanofi | 2 | $32 |
| ZOLL Respicardia, Inc. | 1 | $27 |
| Insmed, Inc. | 1 | $21 |
| Amgen | 1 | $17 |
| Verona Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$3,173
- UPTRAVI$344
- OPSUMIT$344
- FLOWTRIEVER CATHETER, S$292
- CT THROMBECTOMY SYSTEM KIT$292
- Inspire Upper Airway Stimulation System$125
- TruClear$123
- BREZTRI$115
How this compares
$7,033 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 199 | $153,120 |
| Fasenra PenBenralizumab | 16 | $92,328 |
| Spiriva RespimatTiotropium Bromide | 56 | $38,666 |
| Breo ElliptaFluticasone/Vilanterol | 59 | $28,501 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $23,069 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 31 | $20,491 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $8,994 |
| Incruse ElliptaUmeclidinium Bromide | 23 | $8,098 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $5,540 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $4,471 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 149 | $3,822 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $3,143 |
| BreynaBudesonide/Formoterol Fumarate | 11 | $1,909 |
| Montelukast Sodium | 86 | $949 |
| Ventolin HfaAlbuterol Sulfate | 11 | $726 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $169 | $210,210312 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $135 | $44,20668 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $208 | $32,06360 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Jacksonville
- Leighanne MeadeJacksonville$98K
- Jori TaylorJacksonville$48K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.